Aspira Pathlab & Diagnostics Ltd - 540788 - Inauguration Of A New Diagnostics Center Today.
Aspira Pathlab & Diagnostics Limited today has inaugurated new Diagnostics Center named Bluecross Diagnostics Center in Mumbai at Malad (West) location. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure in Form C from Mrs. Geeta Paresh Bhanushali pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI(Prohibition of Insider Trading)Regulation, 2015. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for December 31, 2023 financial results as per regulation 47 of the SEBI(LODR)Regulation,2015. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Cessation
Mr. Arvind Bhanushali (DIN:00011903) has tendered resignation from the post of the Non-Executive & Non-Independent Director & as a member of Audit Committee of the Company with the closure of the business hours February 13, 2024. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate
Mr. Arvind Bhanushali (DIN:00011903) has tendered resignation from the post of the Non-executive & Non-Independent Director of the Company with the closure of business hours February 13, 2024 Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Furnishing Un Audited Financial Results For The Quarter & Nine Months Ended December 31, 2023 Alongwith The Limited Review Report
Unaudited Financial Results for the quarter and nine months ended December 31, 2023. Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended December 31, 2023 In The Board Meeting To Be Held On February 13, 2024
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2023 in the Board Meeting to be held on February 13, 2024 and to consider any other business with the permission of the Chair. Aspira Pathlab & Diagnostics Ltd - 540788 - Cancellation of Board Meeting
The Board Meeting to be held on 10/02/2024 Stands Cancelled. Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended December 31, 2023 And To Consider Any Other Matter With The Permission Of The Chair.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31, 2023 and to consider any other matter with the permission of the Chair. Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74(5) of SEBI (DP)Regulation, 2018 for the quarter ended December 31, 2023.